2879-20-1 1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)ethanone 76143, abenzodioxans compound, is more and more widely used in various.
With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.2879-20-1,1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)ethanone,as a common compound, the synthetic route is as follows.
General procedure: A 10 mL glass flask equipped with a magnetic stir bar wascharged with a methyl ketone (1 mmol) and dissolved in MeCN (2 mL). To thethermostated solution NH4NO3 (10-25 mol %), I2 (50 mol %) and H2SO4(aqueous 96% solution, 10-20 mol %) were added and the flask was furtherequipped with a balloon filled with air (1 L) and magnetically stirred at 60 C.The consumption of starting material was monitored by TLC. After completionof the reaction, the mixture was cooled to room temperature, diluted withEtOAc (10 mL), and insoluble material identified as ammonium sulfate wasfiltered off. The filtrate neutralized with NaHCO3 (aqueous 10% solution, 2 mL)and Na2S2O3 (aqueous 10% solution, 2 mL) and phase was separated. The waterphase was washed with EtOAc additionally two times (2 5 mL). The combinedorganic phase was dried over anhydrous Na2SO4 and the solvent distilled underreduced pressure. The crude product obtained was analyzed by 1H NMR. Finallythe crude product was purified using column chromatography (SiO2, n-hexane/CH2Cl2 elution) and preparative thin layer chromatography to afford purematerial, which was compared to authentic samples. Detailed data, concerningcatalyst loading, reaction times, yields of pure products and their spectroscopicand other identification data are given in SI in the chapter Characterization dataof isolated final products. Characterization, for example, 1-(9H-fluoren-2-yl)-2-iodoethanone (2i): 1-(9H-Fluoren-2-yl)ethanone (1 mmol, 208.3 mg), NH4NO3(0.15 mmol, 12 mg), I2 (0.50 mmol, 126.7 mg), H2SO4 (aqueous 96% solution,0.10 mmol, 5.56 lL), 2 mL MeCN, balloon filled with 1 L of air, 60 C, 20 h were used; crystallization from acetone; yield: 187.2 mg (55%) yellow solid, mp 163-164 C. 1H NMR (303 MHz, CDCl3+two drops of DMSO, 25 C, TMS): d (ppm) 3.92 (s,2H), 4.41 (s, 2H), 7.32-7.44 (m, 2H), 7.54-7.59 (m, 1H), 7.77-7.84 (m, 2H), 7.96-8.02(m, 1H), 8.13 (s, 1H); 13C NMR (76.2MHz, CDCl3+two drops of DMSO, 25 C): d(ppm) 2.3, 36.6, 119.6, 120.7, 125.0, 125.3, 126.9, 128.1, 128.1, 131.5, 139.9, 143.2,144.3, 146.8, 192.4;MS (ESI):m/z 335 ((M+H)+, 100%);HR-MS (ESI):m/z = 334.9925,calcd for C15H12IO: 334.9933; Anal. calcd for C15H11IO: C, 53.92; H, 3.32; found: C,54.39; H, 3.05. 3-(2-Iodoacetyl)-2H-chromen-2-one (2o): 3-Acetyl-2H-chromen-2-one (1 mmol, 188.2mg), NH4NO3 (0.20 mmol, 16 mg), I2 (0.50 mmol, 126.7mg),H2SO4 (aqueous 96% solution, 0.1 mmol, 5.56 lL), 2mLMeCN, balloon filledwith 1 Lof air, 60 C, 23 h were used; column chromatography (SiO2, CH2Cl2); yield:182.2mg (58%), yellow solid; mp 135-138 C. 1H NMR (303.0 MHz, CDCl3, 25C,TMS): d (ppm) 4.68 (s, 2H), 7.34-7.46 (m, 2H), 7.64-7.76 (m, 2H), 8.66 (s, 1H); 13CNMR (76.2MHz, CDCl3, 25 C): d (ppm) 6.8, 116.7, 118.1, 121.4, 125.1, 130.2, 134.9,149.5, 155.3, 158.6, 190.1; MS (ESI): m/z 314.9 ((M+H)+, 100%); HR-MS (ESI): m/z = 314.9523, calcd for C11H8IO3: 314.9518.
2879-20-1 1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)ethanone 76143, abenzodioxans compound, is more and more widely used in various.
Reference£º
Article; Prebil, Rok; Stavber, Stojan; Tetrahedron Letters; vol. 55; 41; (2014); p. 5643 – 5647;,
Benzodioxan
1,4-Benzodioxane | C8H8O2 – PubChem